BLUE - Bluebird bio sinks as finance chief resigns

Bluebird bio (NASDAQ:BLUE) is trading ~17% lower in the pre-market Monday after the commercial-stage biotech company announced the resignation of its Chief Financial Officer, Gina Consylman, effective Apr. 03. Consylman gave the notice of her resignation on Mar. .04, Bluebird bio (BLUE) said in a regulatory filing on Monday, adding that the company expects to appoint its Chief Business Officer, Jason F. Cole as principal financial officer. Cole was named the company’s chief business officer in Nov. 2021 after a stint as its chief operating and legal officer from Feb. 2019. Before that, Mr. Cole served as bluebird’s (BLUE) Chief Legal Officer since March 2016. The departure of its finance chief comes soon after the company’s lower than expected financials for Q4 2021.

For further details see:

Bluebird bio sinks as finance chief resigns